Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days
Pharming Group N.V. announced participation in the Guggenheim Healthcare Talks focused on Genomic Medicines and Rare Disease Days, scheduled for April 3-4, 2023, in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pharming Group N.V. announced participation in the Guggenheim Healthcare Talks focused on Genomic Medicines and Rare Disease Days, scheduled for April 3-4, 2023, in New York. CEO Sijmen de Vries and CCO Stephen Toor will feature in a fireside chat on April 3 at 15:20 ET. Interested investors can access a live webcast and replay on Pharming's website. Additionally, they will be available for one-on-one meetings during the conference. Pharming is dedicated to developing treatments for rare diseases and operates globally, serving patients in over 30 markets.
Details
News Market Reaction – PHAR
The recorded move for PHAR in the trading session of this news was -4.78%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LEIDEN,
A live webcast and replay of the fireside chat can be found in the "Upcoming Events" and "News" sections of Pharming's website.
For more information about the conference, or to schedule a one-to-one with
About
Logo - https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/pharming-to-present-at-the-guggenheim-healthcare-talks--genomic-medicines-and-rare-disease-days-301786069.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.